Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00810 |
| Species: | Homo sapiens |
| Position : | chr20:44430820-44433428 |
| Year: | 2011 |
| Title: | Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 21556051 |
| MONDO: | MONDO:0008315 |
| Tissue: | prostate gland |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | PC-3 |
| CVCL ID: | CVCL_0035 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; 3C; Western blot |
| Target gene : | UBE2C |
| TF name : | FOXA1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXA1 | AndrogenReceptor | netpath | 167 |
| FOXA1 | Direct p53 effectors | pid | 141 |
| FOXA1 | FOXA1 transcription factor network | pid | 45 |
| FOXA1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| FOXA1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00807 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00808 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00809 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00811 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00812 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00813 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |
| E_00814 | chr20:44430820-44433428 | prostate gland | malignant cell | prostate cancer |